Evaluation of the Axonemal Dynein Heavy Chain 5 and Creatine Kinase Concentration in Cervical Fluid for Early Detection of the Ectopic Pregnancy

checkorphan
Learn more about:
Ectopic pregnancy
Related Clinical Trial
Reproductive Outcomes After a Previous Episode of Tubal Ectopic Pregnancy in Patients Managed Expectantly and Surgically Relationship Between Ectopic Pregnancy and Thyroid Disorders Medical Treatment in Ectopic Tubal Pregnancy Evaluation of Different Doses of Letrozole in Ectopic Pregnancy Evaluation of Ipsilateral Tubal Patency After Conservative Medical or Surgical Treatment. Improving Mental Health Following Early PREgnancy Loss Using a Brief Cognitive Task Expectant Management of Ectopic Pregnancy Psychological Impact of Pregnancy of Unknown Location Assessment of Biomarkers in Pregnancy on Unknown Location and Ectopic Pregnancy Comparative Study on the Efficacy of Ovarian Stimulation Protocols on the Success Rate of ICSI in Female Infertility Hysteroscopic Metroplasty in Unexplained Infertile Women With Dysmorphic Uterus Cornual Wedge Resection Outcome Pregnancies of Uncertain Location or Viability Research Randomized Population-Based Study on Chlamydia Trachomatis Screening Sonographic Assessment and Visualization of Ectopics in Emergency Medicine Kisspeptin Levels in Early Pregnancy RCT for Women With a Persisting Pregnancy of Unknown Location Optimal Treatment for Women With a Persisting Pregnancy of Unknown Location Activin A and Inhibin A in Predicting Outcome of Pregnancies of Unknown Location After Assisted Reproductive Technology Evaluation of the Axonemal Dynein Heavy Chain 5 and Creatine Kinase Concentration in Cervical Fluid for Early Detection of the Ectopic Pregnancy Vitamin D in Ectopic Pregnancies Laparoscopic Tubal Preservation Surgery BHCG Level in Day 4,7, in Comparison to Day 10 as an Indicator for Treatment Success The Correlation Between Uterine Endometrial Pattern and Ectopic Pregnancy Adnexal Mass After Methotrexate Treatment for Ectopic Pregnancies The Impact of Salpingectomy and Single Dose Systemic Methotrexate Treatments on Ovarian Reserve in Ectopic Pregnancy Effectiveness Of Expectant Management In The Tubal Ectopic Pregnancy Methotrexate Treatment for Ectopic Pregnancy Comparison of Two Different Approaches in the Surgical Treatment of Tubal Ectopic Pregnancy Two-Dose Methotrexate for Ectopic Pregnancy Ectopic Pregnancy Biomarkers The Aromatase Inhibitor and Gnrh Antagonist Versus Methotrexate for Management of Undisturbed Ectopic Pregnancy Are Serum Levels of Vascular Endothelial Growth Factor a Marker for the Early Diagnosis of Ectopic Pregnancy? Risk Factors of Ectopic Pregnancy Assessment of Biomarkers in Ectopic Pregnancy Risk of Ectopic Pregnancy and Variation of Luteal Estradiol and Progesterone Levels in IVF

Brief Title

Evaluation of the Axonemal Dynein Heavy Chain 5 and Creatine Kinase Concentration in Cervical Fluid for Early Detection of the Ectopic Pregnancy

Brief Summary

      Patients who have doubt for ectopic pregnancy will be enrolled for our study. These patients
      will be determined with using irregular increased human chorionic gonadotropin (beta-HCG)
      results and no embryo reported ultrasonography results. Plasma and cervical fluid samples
      will be taken from these patients and axonemal dynein heavy chain 5 and creatine kinase
      levels of samples will be compared between patients who have doubt for ectopic pregnancy and
      patients who have intrauterine pregnancy. Concentration of these proteins in samples will be
      evaluated. If any difference will be found between groups in favour of ectopic pregnancy,
      these results might be interpreted as these proteins useful for early detecting of the
      ectopic pregnancy.

Study Type

Observational

Primary Outcome

Concentration of Axonemal Dynein Heavy Chain 5

Condition

Ectopic Pregnancy

Intervention

Collecting cervical liquid and sera samples

Study Arms / Comparison Groups

 Doubt for ectopic pregnancy group
Description:  This group participants have doubt for ectopic pregnancy in terms of beta-HCG pregnancy follow-up results and ultrasonography results.

Publications

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status

Other

Estimated Enrollment

85

Start Date

September 2016

Completion Date

November 2018

Primary Completion Date

June 2018

Eligibility Criteria

        Inclusion Criteria:

          -  Doubted ectopic pregnancy

          -  Without any finding about intrauterine pregnancy in ultrasonography results

          -  Without any vaginal bleeding

          -  Having irregular pregnancy test results

          -  Beta-HCG results should be at least upper than 100 milli-International unit (mIU/ml)

          -  Having fist trimester pregnancy for intrauterine pregnancy group

          -  Without any emergency findings

        Exclusion Criteria:

          -  Doubted incomplete abortion

          -  Having vaginal bleeding

          -  Having ultrasound results which include intrauterine embryo report

          -  Having lower than 100 mIU/ml beta-HCG results

          -  Without fetal heart rate in intrauterine pregnancy group

          -  Having older than fist trimester pregnancy for intrauterine pregnancy group

          -  Having emergency findings

Gender

Female

Ages

18 Years - 45 Years

Accepts Healthy Volunteers

No

Contacts

, ,

Location Countries

Turkey

Location Countries

Turkey

Administrative Informations

NCT ID

NCT02995356

Organization ID

2.101.2015.0076

Responsible Party

Principal Investigator

Study Sponsor

Ege University

Study Sponsor

, ,

Verification Date

March 2019